André T - Search Results

1

Cetuximab efficacy in patients treated routinely in university hospitals.

Bachet JB, Afchain P, Fermanian C, Bouchahda M, Mitry E, Landi B, André T, Lièvre A, Louvet C, Aegerter P, Levi F, Rougier P. Bachet JB, et al. Among authors: andre t. Gastroenterol Clin Biol. 2007 Nov;31(11):941-9. doi: 10.1016/s0399-8320(07)78302-1. Gastroenterol Clin Biol. 2007. PMID: 18166882 Free article.

2

[Chemotherapy of colorectal cancers with metastases].

de Gramont A, Louvet C, André T, Tournigand C, Raymond E, Krulik M. de Gramont A, et al. Among authors: andre t. Presse Med. 1996 Nov 16;25(35):1678-82. Presse Med. 1996. PMID: 8977579 Review. French.

3

Bimonthly high dose leucovorin and 5-fluorouracil 48-hour continuous infusion in patients with advanced colorectal carcinoma. Groupe d'Etude et de Recherche sur les Cancers de l'Ovaire et Digestifs (GERCOD).

Beerblock K, Rinaldi Y, André T, Louvet C, Raymond E, Tournigand C, Carola E, Favre R, de Gramont A, Krulik M. Beerblock K, et al. Among authors: andre t. Cancer. 1997 Mar 15;79(6):1100-5. Cancer. 1997. PMID: 9070486 Clinical Trial.

4

Oxaliplatin with high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancer.

de Gramont A, Vignoud J, Tournigand C, Louvet C, André T, Varette C, Raymond E, Moreau S, Le Bail N, Krulik M. de Gramont A, et al. Among authors: andre t. Eur J Cancer. 1997 Feb;33(2):214-9. doi: 10.1016/s0959-8049(96)00370-x. Eur J Cancer. 1997. PMID: 9135491 Clinical Trial.

5

[Modulation of 5-fluorouracil with folinic acid in advanced colorectal cancers. Groupe d'étude et de recherche sur les cancers de l'ovaire et digestifs (GERCOD)].

de Gramont A, Louvet C, André T, Tournigand C, Raymond E, Molitor JL, Krulik M. de Gramont A, et al. Among authors: andre t. Rev Med Interne. 1997;18 Suppl 4:372s-378s. doi: 10.1016/s0248-8663(97)83768-x. Rev Med Interne. 1997. PMID: 9365715 Review. French.

6

[Oxaliplatin, folinic acid and 5-fluorouracil (folfox) in pretreated patients with metastatic advanced cancer. The GERCOD].

de Gramont A, Tournigand C, Louvet C, André T, Molitor JL, Raymond E, Moreau S, Vignoud J, Le Bail N, Krulik M. de Gramont A, et al. Among authors: andre t. Rev Med Interne. 1997;18(10):769-75. doi: 10.1016/s0248-8663(97)89966-3. Rev Med Interne. 1997. PMID: 9500010 Clinical Trial. French.

7

A review of GERCOD trials of bimonthly leucovorin plus 5-fluorouracil 48-h continuous infusion in advanced colorectal cancer: evolution of a regimen. Groupe d'Etude et de Recherche sur les Cancers de l'Ovaire et Digestifs (GERCOD).

de Gramont A, Louvet C, André T, Tournigand C, Krulik M. de Gramont A, et al. Among authors: andre t. Eur J Cancer. 1998 Apr;34(5):619-26. doi: 10.1016/s0959-8049(97)00364-x. Eur J Cancer. 1998. PMID: 9713264 Review.

8

[Adenocarcinoma of the pancreas. General characteristics].

André T, Balosso J, Louvet C, Gligorov J, Callard P, de Gramont A, Izrael V. André T, et al. Presse Med. 1998 Mar 21;27(11):533-6. Presse Med. 1998. PMID: 9767968 Review. French.

9

[Adenocarcinoma of the pancreas. Therapeutic strategies].

André T, Balosso J, Louvet C, Houry S, Vaillant JC, Touboul E, Lotz JP, de Gramont A, Izrael V. André T, et al. Presse Med. 1998 Mar 21;27(11):539-45. Presse Med. 1998. PMID: 9767970 Review. French.

10

Bimonthly high-dose leucovorin, 5-fluorouracil infusion and oxaliplatin (FOLFOX3) for metastatic colorectal cancer resistant to the same leucovorin and 5-fluorouracil regimen.

André T, Louvet C, Raymond E, Tournigand C, de Gramont A. André T, et al. Ann Oncol. 1998 Nov;9(11):1251-3. doi: 10.1023/a:1008475122124. Ann Oncol. 1998. PMID: 9862058 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

544 results

Search Page